Child-resistant packages
- Published: February 27, 2020
- Last updated: December 5, 2024
To prevent the accidental ingestion of medicinal products, such products must be kept out of sight and reach of children. In addition, it is appropriate to make access to some medicinal products by children more difficult by packaging them more securely.
A more protected way may be to use a blister pack or jar/bottle with a child-resistant closure.
The Swedish Medical Products Agency (Swedish MPA) has drawn up a list of pharmaceutical substances for which the ingestion of a small quantity, such as a single tablet, results in that the child needs to be observed or treated in a hospital. The list has been drawn up on the basis of the experience of the Swedish Poison Information Centre and the assessment of the properties of substances.
Requirements regarding child-resistant packaging
For medicinal products which contain these substances, the Swedish MPA may require child-resistant packaging to be used, particularly unless the pharmaceutical form or formulation can be considered as reducing the risk. The list is not exhaustive and the Swedish MPA may also require child-resistant packaging to be used for medicinal products with other substances, when this is considered to be justified.
|
Substance |
Use |
|
Amifampridine |
Multiple sclerosis |
|
Amiodarone |
Antiarrythmic |
|
Atomoxetine |
ADHD |
|
Bromocriptine |
Parkinsons disease |
|
Buprenorphine |
Analgesic, opioid addiction |
|
Bupropion |
Antidepressant |
| Cariprazine |
Neuroleptics |
| Cenobamate |
Antiepileptic |
| Cladribine |
Multiple sclerosis etc. |
|
Clomipramine |
Antidepressant |
|
Chloroquine |
Malaria |
|
Clozapine |
Neuroleptics |
|
Dexamfetamine |
ADHD |
|
Diltiazem |
Calcium antagonists |
|
Disopyramide |
Antiarrythmic |
|
Dronedarone |
Antiarrythmic |
|
Edoxaban |
Anticoagulant |
|
Fampridine |
Multiple sclerosis etc. |
|
Fentanyl |
Analgesic |
|
Fingolimod |
Multiple sclerosis etc. |
|
Flecainide |
Antiarrythmic |
|
Flunitrazepam |
Sleeping pills |
| Galantamine |
Anti-dementia |
|
Glibenclamide |
Diabetes |
|
Glimepiride |
Diabetes |
|
Glipizide |
Diabetes |
|
Guanfacine |
ADHD |
|
Hydromorphone |
Analgesic |
|
Hydroxychloroquine |
Malaria |
|
Isradipine |
Calcium antagonists |
|
Ivabradine |
Angina pectoris |
|
Ketobemidone |
Analgesic |
| Lacosamide |
Antiepileptic |
|
Levothyroxine* |
Hypothyreosis |
|
Lisdexamfetamine |
ADHD |
|
Maprotiline |
Antidepressant |
| Mavacamten |
Cardiac preparation |
|
Methadone |
Analgesic, opioid addiction |
|
Methylphenidate |
ADHD |
|
Morphine |
Analgesic |
|
Nateglinide |
Diabetes |
|
Nifedipine |
Calcium antagonists |
| Nimodipine |
Calcium antagonists |
|
Olanzapine |
Neuroleptics |
|
Oxycodone |
Analgesic |
| Ozanimod |
Multiple sclerosis etc. |
|
Paliperidone |
Neuroleptics |
| Perampanel |
Antiepileptic |
| Pergolide |
Endocrine disorders (Vet) |
|
Pimobendan |
Cardiac stimulant (Vet) |
| Ponesimod |
Multiple sclerosis etc. |
|
Pramipexole |
Parkinsons disease |
|
Propafenone |
Antiarrythmic |
|
Propranolol |
Beta-receptor blocker |
|
Quetiapine |
Neuroleptics |
|
Repaglinide |
Diabetes |
|
Risperidone |
Neuroleptics |
|
Rivaroxaban |
Anticoagulant |
| Rivastigmine |
Anti-dementia |
|
Ropinirole |
Parkinsons disease |
| Siponimod |
Multiple sclerosis etc. |
|
Sotalol |
Beta-receptor blocker |
|
Tapentadol |
Analgesic |
|
Theophylline |
Lung disease |
|
Tramadol |
Analgesic |
| Tranylcypromine |
Antidepressant |
|
Venlafaxine |
Antidepressant |
|
Verapamil |
Calcium antagonists |
* The ingestion of a smaller amount is not dangerous, but the Swedish MPA has concluded that currently authorised tablets are so small that children could easily ingest large quantities.